Non-A, Non-B Hepatitis Transmission in Chimpanzees: a Project of the Transfusion-transmitted Viruses Study Group
Overview
Authors
Affiliations
Experimental transmission of non-A, non-B hepatitis was apparently accomplished in 5 chimpanzees following inoculation with presumably infectious human sera. Administration of sera from implicated donors with normal alanine aminotransferase (ALT) values, as well as from those with abnormal ALT levels, resulted in the development of ALT abnormalities in the inoculated chimpanzees. Transmission from donors with normal ALT values implies that healthy carriers of non-A, non-B virus exist. Evidence is presented which indicates that a period of viremia precedes the clinical illness by at least 12 days.
Contemporary Insights into Hepatitis C Virus: A Comprehensive Review.
Sallam M, Khalil R Microorganisms. 2024; 12(6).
PMID: 38930417 PMC: 11205832. DOI: 10.3390/microorganisms12061035.
Mouse Models for Studying HCV Vaccines and Therapeutic Antibodies.
Gaska J, Ding Q, Ploss A Methods Mol Biol. 2018; 1911:481-503.
PMID: 30593647 PMC: 6699619. DOI: 10.1007/978-1-4939-8976-8_33.
Lanford R, Walker C, Lemon S ILAR J. 2017; 58(2):172-189.
PMID: 29045731 PMC: 5886334. DOI: 10.1093/ilar/ilx028.
Advanced molecular surveillance of hepatitis C virus.
Rossi L, Escobar-Gutierrez A, Rahal P Viruses. 2015; 7(3):1153-88.
PMID: 25781918 PMC: 4379565. DOI: 10.3390/v7031153.
Adaptive immunity to the hepatitis C virus.
Walker C Adv Virus Res. 2010; 78:43-86.
PMID: 21040831 PMC: 6171124. DOI: 10.1016/B978-0-12-385032-4.00002-1.